Check the time stamp on this data. Updated AI-Generated Signals for Aligos Therapeutics Inc. (ALGS) available here: ALGS.

Aligos Therapeutics (ALGS) has entered into a securities purchase agreement for a private placement that is expected to result in gross ...

In this article, we are going to take a look at where Aligos Therapeutics, Inc. (NASDAQ:ALGS) stands against the other stocks. One of the strongest stock market anomalies is the momentum effect ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical study Funding expected to extend cash runway into the second half of 2026 SOUTH SAN FRANCISCO, Calif., Feb. 12, 2025 (GLOBE ...

Game Designer John Larson discusses approaches to Legend and class changes, as well as how much of it is influenced by Apex Legends' esports league ...

FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including ...

A shift in the Apex Legends meta is finally upon us. Though Lifeline was the legend of interest last season, Season 24 is changing the landscape significantly f ...

Apex Legends is always switching up its gameplay, whether it be by balancing popular legends or revamping the armor system. The latest update introducing Season ...

Apex Legends Season 24 features a plethora of weapon changes, all of which have been incorporated to shift the concrete gun ...

SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a company specializing in therapies for liver and viral diseases with a current market capitalization of $96.58 million, announced today ...